Even otherwise, L-carnitine is widely taken as a supplement by healthy individuals, but its lipid metabolism efficiency under conditions of excessive intake has been questioned 1
GLP-1 agonists are being used in combination with basal insulin (Dungan & DeSantis, 2016), although this is not an FDA-approved indication (see rxlist.com) they should not be used as a substitute for basal insulin, as this has been found to result in a decline in glycemic control)(Dungan & DeSantis, 2016) Clinical trials indicate it can reduce HbA1c by ~0.8% Undergoes renal clearance, with dosage reduction needed if creatinine clearance falls to 25 mL/min, while European guidelines recommend a lower eGFR limit of 20 ml/min (Thomas et al, 2023)
The protocols in this guide apply to compounded, pharmacy-grade BPC-157 only
L-Carnitine is also indicated for acute and chronic treatment of patients with an inborn error of metabolism which results in a secondary carnitine deficiency
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials
It means the idea is promising when used carefully and selectively